Aarti Drugs Buyback 2023 Description – Aarti Drugs was established in the year 1984 and forms part of the USD 900 Million Aarti Group of Industries with a robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, and Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary – Pinnacle Life Science Private Limited.
Products under APIs include Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin, etc. whereas Specialty Chemicals include Benzene Sulphonyl Chloride, Methyl Nicotinate, etc.
Aarti Drugs Share Buyback 2023 Details
Aarti Drugs Buyback Dates | 9 – 17 August 2023 |
Aarti Drugs Buyback Price | INR 900 per share |
Market Price on Buyback Approval | INR 508.5 per share |
Buyback Premium on Market Price | 76.99% |
Buyback Offer Size (Shares) | 6,65,000 shares |
Buyback Offer Size (Amount) | INR 59.85 crore |
Offer Type | Tender |
Promoter Participation | Yes |
Face Value | INR 10 per share |
Listing At | NSE, BSE |
Aarti Drugs Buyback Dates (Timeline)
Board Meeting Intimation for Buyback Proposal | 14 July 2023 |
Buyback Approval Date | 21 July 2023 |
Public Announcement of Buyback | 25 July 2023 |
Aarti Drugs Buyback Record Date | 4 August 2023 |
Buyback Opening Date | 9 August 2023 |
Buyback Closing Date | 17 August 2023 |
Cut-off Date to receive completed tender forms by Registrar | 17 August 2023 |
Verification Date by the Registrar | 21 August 2023 |
Return of unaccepted shares by Registrar | 24 August 2023 |
Extinguishment of accepted shares | 4 September 2023 |
Aarti Drugs Buyback 2023 Documents
Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback
Aarti Drugs Buyback Entitlement Ratio
Shareholder Category | Entitlement Ratio | Entitlement Ratio (in %) |
Small Shareholders (less than INR 2 Lakh on record date) | 2/157 | 1.27 |
General category (for all other Eligible Shareholders) | 1/150 | 0.67 |
Small Shareholder is defined as shareholder who holds shares worth less than INR 2,00,000 as on record date.
Aarti Drugs Financial Performance
FY 2021 | FY 2022 | FY 2023 | |
Revenue | 2,155 | 2,489 | 2,716 |
Total Expenses | 1,714 | 2,156 | 2,410 |
Net income | 280 | 205 | 166 |
Calculation of Investment in Buyback
Maximum market value of a share holder as on record date | INR 2,00,000 |
Buyback price per share | INR 900 |
Maximum shares for small shareholder (2,00,000/900) | 223 shares * |
Closing price of stock as on 21 July 2023 | INR 508.5** |
Maximum amount invested in buyback (INR 508.5 x 223 shares) | INR 113,395.5 |
** For simplicity, we have considered price on buyback approval date
Aarti Drugs Buyback Acceptance Ratio
Shares Tendered | Buyback Entitlement | Acceptance ratio | Buyback Profit | Profit in % |
223 | 3 | 3 (100%) | 1,174.5 | 1.04 |
223 | 3 | 6 (200%) | 2,349.0 | 2.07 |
223 | 3 | 9 (300%) | 3,523.5 | 3.11 |
Registrar of Aarti Drugs Buyback 2023
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli West
Mumbai – 400 083, Maharashtra
Phone:Â +918108114949
Email:Â [email protected]
Website: www.linkintime.co.in
Manager of Aarti Drugs Buyback 2023
INGA VENTURES PRIVATE LIMITED
1229, Hubtown Solaris, N.S. Phadke Marg,
Opp. Telli Galli, Andheri (East),
Mumbai, Maharashtra – 400069
Tel. No.:Â +91 022 6854 0808
Email:Â [email protected]
Website:Â www.ingaventures.com
Process to Participate in Aarti Drugs Buyback
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Frequently Asked Questions
What are Aarti Drugs buyback dates?
Aarti Drugs share buyback opens on 9 August 2023 and closes on 9 August 2023.
Which type of is Aarti Drugs buyback offer?
Aarti Drugs buyback is a tender offer.
What is Aarti Drugs buyback price?
Aarti Drugs buyback price is INR 900 per share.
What is Aarti Drugs buyback record date?
Aarti Drugs buyback record date is 4 August 2023.
How to participate in Aarti Drugs share buyback?
Aarti Drugs share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.
Mere aratidrug ke 90 share buyback hue he.ac me pese Kab aaenge